Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study

OBJECTIVE: Several molecules are involved in the pathogenesis of a new bone formation in ankylosing spondylitis (AS). The aim of this study was to evaluate the serum levels of sclerostin in patients with AS as a possible biomarker and to investigate any correlations with radiographic damage, disease...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Immunol Res
Asıl Yazarlar: Perrotta, Fabio Massimo, Ceccarelli, Fulvia, Barbati, Cristiana, Colasanti, Tania, De Socio, Antonia, Scriffignano, Silvia, Alessandri, Cristiano, Lubrano, Ennio
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Hindawi 2018
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5954944/
https://ncbi.nlm.nih.gov/pubmed/29854850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/9101964
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller